Sabine Seiler

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

Carsten Denkert, Fenja Seither, Andreas Schneeweiß et al. · The Lancet Oncology · 2021 · 561 citations

Medicine, Cancer Biology, Oncology +16

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

Sibylle Loibl, Frederik Marmé, Miguel Martín et al. · Journal of Clinical Oncology · 2021 · 324 citations

Medicine, Oncology, Pharmacology +17

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

Peter A. Fasching, Theresa Link, Jan Hauke et al. · Annals of Oncology · 2020 · 144 citations · Full text

Medicine, Cancer Biology, Oncology +17

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

Christoph Engel, Kerstin Rhiem, Eric Hahnen et al. · BMC Cancer · 2018 · 132 citations · Full text

Life Sciences, Genetics, Oncology +16

Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men

Mattea Reinisch, Sabine Seiler, Tanja Hauzenberger et al. · JAMA Oncology · 2021 · 48 citations · Full text

Medicine, Endocrinology, Oncology +15